pI: 9.6543 |
Length (AA): 389 |
MW (Da): 42852 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
155 | 389 | 1b5s (A) | 193 | 424 | 31.00 | 0 | 1 | 1.00561 | -0.24 |
160 | 386 | 3mae (A) | 187 | 409 | 35.00 | 0 | 1 | 1.05805 | -0.71 |
162 | 389 | 3l60 (A) | 168 | 390 | 27.00 | 0 | 1 | 0.972618 | -0.77 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128029)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G13930 | dihydrolipoamide acetyltransferase, long form protein |
Arabidopsis thaliana | AT1G54220 | dihydrolipoyllysine-residue acetyltransferase component 3 of pyruvate dehydrogenase complex |
Brugia malayi | Bm1_10875 | dihydrolipoamide S-acetyltransferase |
Candida albicans | CaO19.6561 | dihydrolipoamide acetyltransferase |
Candida albicans | CaO19.13914 | dihydrolipoamide acetyltransferase |
Candida albicans | CaO19_6561 | hypothetical protein |
Caenorhabditis elegans | CELE_F23B12.5 | Protein DLAT-1 |
Chlamydia trachomatis | CT_247 | dihydrolipoamide acetyltransferase |
Dictyostelium discoideum | DDB_G0277847 | dihydrolipoamide acetyltransferase |
Drosophila melanogaster | Dmel_CG5261 | CG5261 gene product from transcript CG5261-RB |
Echinococcus granulosus | EgrG_000321550 | Biotin lipoyl attachment |
Echinococcus multilocularis | EmuJ_000321550 | Biotin lipoyl attachment |
Homo sapiens | ENSG00000150768 | dihydrolipoamide S-acetyltransferase |
Leishmania braziliensis | LbrM.35.2870 | dihydrolipoamide acetyltransferase precursor, putative |
Leishmania donovani | LdBPK_362790.1 | dihydrolipoamide acetyltransferase precursor, putative |
Leishmania infantum | LinJ.36.2790 | dihydrolipoamide acetyltransferase precursor, putative |
Leishmania major | LmjF.36.2660 | dihydrolipoamide acetyltransferase precursor, putative |
Leishmania mexicana | LmxM.36.2660 | dihydrolipoamide acetyltransferase precursor, putative |
Loa Loa (eye worm) | LOAG_16098 | hypothetical protein |
Loa Loa (eye worm) | LOAG_10883 | dihydrolipoamide S-acetyltransferase |
Loa Loa (eye worm) | LOAG_15745 | hypothetical protein |
Mus musculus | ENSMUSG00000000168 | dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex) |
Oryza sativa | 4339859 | Os06g0105400 |
Oryza sativa | 4343003 | Os07g0410100 |
Oryza sativa | 4328010 | Os02g0105200 |
Saccharomyces cerevisiae | YNL071W | dihydrolipoyllysine-residue acetyltransferase |
Schistosoma japonicum | Sjp_0216460 | ko:K00627 pyruvate dehydrogenase E2 component (dihydrolipoamide [EC2.3.1.12], putative |
Schistosoma japonicum | Sjp_0134970 | Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial precursor, putative |
Schistosoma mansoni | Smp_194460 | dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase |
Schmidtea mediterranea | mk4.000019.10 | Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial |
Schmidtea mediterranea | mk4.065814.00 | |
Trypanosoma brucei gambiense | Tbg972.10.9270 | dihydrolipoamide acetyltransferase precursor, putative |
Trypanosoma brucei | Tb927.10.7570 | dihydrolipoamide acetyltransferase E2 subunit, putative |
Trypanosoma brucei | Tb11.v5.0774 | dihydrolipoamide acetyltransferase precursor, putative |
Trypanosoma congolense | TcIL3000_10_6510 | dihydrolipoamide acetyltransferase E2 subunit, putative |
Trypanosoma cruzi | TcCLB.509717.20 | dihydrolipoamide acetyltransferase precursor, putative |
Trypanosoma cruzi | TcCLB.510105.170 | dihydrolipoamide acetyltransferase precursor, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0747 | branched-chain alpha-keto acid dehydrogenase subunit E2 |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.7570 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.7570 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.7570 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.10.7570 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F23B12.5 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F23B12.5 | Caenorhabditis elegans | slow growth | wormbase |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.